+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Measles vaccination: III. Serologic responses to immunization with purified hemagglutinin



Measles vaccination: III. Serologic responses to immunization with purified hemagglutinin



Acta Paediat Scand 54(6): 581-586



A comparative study was made of the immunizing effect of purified measles hemagglutinin (TE vaccine) and a formalinized, alum-adsorbed, whole virus preparation (FK vaccine). Three monthly doses of 1.01 ml vaccine were given to 2 groups comprising 40 and 31 children, respectively . Both vaccines gave 100% conversions with almost identical mean neutralization (about 1:180) and HI [hemagglutination inhibition] srum (about 1:600) titers. A difference was found in the CF [complement fixation] tests. The frequency of CF conversion was 80% with the FK vaccine and only 32.5% with the TE vaccine. Blood samples collected 11 months after the administration of the last dose of vaccine were submitted to sero-logical analysis. HI antibodies were still present on a detectable level in 100% of the sera. The reduction in mean titers was 8.5 and 10.6 fold in groups of children given the FK and TE vaccine, respectively. No known exposure to measles occurred during the time of observation. However, 6 months after vaccination one child given the FK vaccine contracted what most likely was mild measles.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 024983806

Download citation: RISBibTeXText


Related references

Measles vaccination. 3. Serologic responses to immunization with purified hemagglutinin. Acta Paediatrica Scandinavica 54(6): 581-586, 1965

Measles vaccination: Serologic responses to vaccination and revaccination with inactivated vaccin. VIIIth International Congress for Microbiology, Abstracts, Montreal, Quebec, Canada No E 32B 6 p 108, 1962

Measles vaccination. I. Serologic responses to vaccination with inactivated vaccine. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine 110: 154-158, 1962

Measles virus specific mucosal and systemic immune responses induced by intranasal immunization with a vaccinia virus vector expressing measles hemagglutinin. 9TH INTERNATIONAL CONGRESS OF IMMUNOLOGY [Author] The 9th International Congress of Immunology : 583, 1995

Measles vaccination. V. The booster effect of purified hemagglutinin in children previously immunized with this product or formalin-killed vaccine. Acta Paediatrica Scandinavica 55(1): 73-78, 1966

Measles Vaccination. I. Serologic Responses To An Inactivated Vaccine. Archiv für die Gesamte Virusforschung 13: 548-558, 1963

Poor serologic responses five to seven years after immunization with high and standard titer measles vaccines. Pediatric Infectious Disease Journal 18(1): 53-57, 1999

Purified influenza vaccine: clinical and serologic responses to varying doses and different routes of immunization. Journal of Infectious Diseases 122(1): 26-32, 1970

Humoral and cellular immune responses following vaccination with purified recombinant hemagglutinin from influenza A (H3N2) virus. Journal of Infectious Diseases 175(2): 342-351, 1997

Characterization of immune responses induced by intramuscular vaccination with DNA vaccines encoding measles virus hemagglutinin and/or fusion proteins. Journal of Virology 79(15): 9854-9861, 2005

Induction of adult-like antibody, Th1, and CTL responses to measles hemagglutinin by early life murine immunization with an attenuated vaccinia-derived NYVAC(K1L) viral vector. Virology 285(1): 12-20, 2001

Successful DNA immunization against measles: neutralizing antibody against either the hemagglutinin or fusion glycoprotein protects rhesus macaques without evidence of atypical measles. Nature Medicine 6(7): 776-781, 2000

Hemagglutinin protein is a primary target of the measles virus-specific HLA-A2-restricted CD8+ T cell response during measles and after vaccination. Journal of Infectious Diseases 195(12): 1799-1807, 2007

Seroprevalence of antibodies to measles, mumps, and rubella, and serologic responses after vaccination among human immunodeficiency virus (HIV)-1 infected adults in Northern Thailand. Bmc Infectious Diseases 16: 190, 2016